Market Overview The Gastroesophageal Reflux Disease Therapeutics Market continues to grow as rising GERD prevalence, linked to lifestyle and dietary factors, sustains demand for both prescription and over-the-counter acid-suppressing therapies. Proton pump inhibitors remain the dominant treatment class, though newer potassium-competitive acid blockers are gaining clinical attention for their...